Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Casanova

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker SubanalysisNatalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, et al.
Blood|June 16, 2021
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell developmentDaniel Alameda, Ibai Goicoechea, Marco Vicari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal GammopathiesLeire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple MyelomaRosalinda Termini, David Žihala, Evangelos Terpos, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker SubanalysisNatalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, et al.
Blood|June 16, 2021
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell developmentDaniel Alameda, Ibai Goicoechea, Marco Vicari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal GammopathiesLeire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple MyelomaRosalinda Termini, David Žihala, Evangelos Terpos, et al.
Pageof 4